Found: 28
Select item for more details and to access through your institution.
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01797-3
- By:
- Publication type:
- Article
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4974, doi. 10.3390/ijms24054974
- By:
- Publication type:
- Article
The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1115, doi. 10.1007/s00520-021-06489-y
- By:
- Publication type:
- Article
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 642, doi. 10.3390/vaccines12060642
- By:
- Publication type:
- Article
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.
- Published in:
- Scientific Reports, 2015, p. 18670, doi. 10.1038/srep18670
- By:
- Publication type:
- Article
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0059981
- By:
- Publication type:
- Article
Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0019234
- By:
- Publication type:
- Article
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 12967, doi. 10.1002/cam4.5968
- By:
- Publication type:
- Article
Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 8, p. 1371, doi. 10.1002/ijc.34817
- By:
- Publication type:
- Article
Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 4, p. 661, doi. 10.1002/ijc.34273
- By:
- Publication type:
- Article
Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
- Published in:
- 2008
- By:
- Publication type:
- journal article
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92774-z
- By:
- Publication type:
- Article
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159146
- By:
- Publication type:
- Article
Ralstonia insidiosa Bacteremia in Patients with Solid Cancer Treated by Means of a Central Venous Catheter.
- Published in:
- Hygiene, 2024, v. 4, n. 2, p. 157, doi. 10.3390/hygiene4020012
- By:
- Publication type:
- Article
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.
- Published in:
- Diagnostics (2075-4418), 2019, v. 9, n. 4, p. 146, doi. 10.3390/diagnostics9040146
- By:
- Publication type:
- Article
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 2, p. 294, doi. 10.3390/cells9020294
- By:
- Publication type:
- Article
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2
- By:
- Publication type:
- Article
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2
- By:
- Publication type:
- Article
Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13763
- By:
- Publication type:
- Article
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220644
- By:
- Publication type:
- Article
The Clinical Value of Nutritional Care before and during Active Cancer Treatment.
- Published in:
- Nutrients, 2021, v. 13, n. 4, p. 1196, doi. 10.3390/nu13041196
- By:
- Publication type:
- Article
The prognostic role of tumor size in early breast cancer in the era of molecular biology.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189127
- By:
- Publication type:
- Article